A COMPARATIVE STUDY OF INTUBATING CONDITIONS BETWEEN ROCURONIUM BROMIDE AND SUXAMETHONIUM FOR INTUBATION IN GENERAL ANAESTHESIA
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2015, Vol 2, Issue 29
Abstract
AIMS: This study was conducted to compare the intubating conditions between Rocuronium Bromide and Suxamethonium for endotracheal intubation in General anaesthesia. MATERIALS AND METHODS: In this prospective randomized controlled study 100 patients posted for different surgeries done under general anaesthesia were included in the study. The first group – Group I or Rocuronium (R) Group received Injection Rocuronium Bromide as the muscle relaxant. The second group- Group II or Suxamethonium (S) group received Injection Suxamethonium as the muscle relaxant. Descriptive statistics that included mean, standard deviation (SD), minimum and maximum values were calculated for each of the two study groups. The student ‘t’ test was used to determine whether significant differences were present in the different variables between the two study groups. The chi-square test was also used to determine significant differences in the various conditions between the groups. Significance for all statistical tests was pre-determined at a probability value (p-value) of 0.05 or less. Only those values which are significant have been mentioned. The patient belonging to Group I received Rocuronium 1 mg/kg as the muscle relaxant. The second group was designated as Group II or Suxamethonium group. These patients received Injection Suxamethonium 1.5mg/kg as the muscle relaxant. RESULTS: In our present study, we have used 3.3xED95 (1mg/kg) of Rocuronium bromide and 1.5 mg/kg of Suxamethonium as the intubating dose, produced good to excellent intubating conditions at 60 seconds as well as 90 seconds after administration. Intubating conditions following Suxamethonium (1.5 mg/kg) were comparable with those after Rocuronium. CONCLUSION: Rocuronium bromide in a dose of 1 mg/kg can be used as an alternative to Suxamethonium 1.5 mg/kg provided the airway has been carefully assessed and no difficulty is anticipated.
Authors and Affiliations
Mydhili K, Padma T, Sreenivasa Rao S
Keywords
Related Articles
- EP ID EP231488
- DOI 10.18410/jebmh/2015/600
- Views 86
- Downloads 0
OUR TEN YEARS’ EXPERIENCE WITH PULSE THERAPY IN PEMPHIGUS- A RETROSPECTIVE ANALYSIS OF 194 CASES
BACKGROUND Pemphigus is a group of autoimmune disease that affect skin and mucous membranes clinically manifested by flaccid blisters because of acantholysis. Pulse therapy was initiated in 1981 to treat the cases of pem...
STUDY ON NONALCOHOLIC STEATOHEPATITIS (NASH) IN PATIENTS OF OBESE, TYPE 2 DIABETES MELLITUS
BACKGROUND Nonalcoholic steatohepatitis (NASH) represents only a part of a wide spectrum of non-alcoholic fatty liver disease (NAFLD) and its prevalence is only 2-3% in the general population. Diabetes mellitus increases...
RETINOBLASTOMA- OUR EXPERIENCE OF INITIAL PRESENTATION ON ULTRASONOGRAPHY
BACKGROUND Vision is one of the most important components of the human sensory system. Retinoblastoma is the most common cancer of the eye in children, commonly seen below 5 years of age. We aimed to study the initial pr...
COMPARISON OF POSTOP SIA IN MSICS WITH STRAIGHT INCISION VERSUS FROWN INCISION
BACKGROUND Surgically-Induced Astigmatism (SIA) is one of the commonest causes of poor postoperative vision even after uneventful cataract surgery. Recent advances have led to a newer concept of “refractive cataract surg...
CORRELATION BETWEEN THE FDG UPTAKE OF PRIMARY TUMOUR AND METASTATIC MEDIASTINAL LYMPH NODES IN NON SMALL CELL LUNG CARCINOMA
BACKGROUND FDG-PET/CT is the current imaging modality of choice in the workup of patients with Non-Small Cell Lung Carcinoma. Mediastinal Lymph nodal status is an important indicator in the staging and prognostication of...